Biodexa Pharmaceuticals's total assets for Q2 2022 were £9.68M, a decrease of -25.02% from the previous quarter. BDRX total liabilities were £2.19M for the fiscal quarter, a -10.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.